All Stories

  1. Hypertension and diabetes, but not leptin and adiponectin, mediate the relationship between body fat and chronic kidney disease
  2. Urinary Kidney Injury Biomarkers Are Associated with Ischemia-Reperfusion Injury Severity in Kidney Allograft Recipients
  3. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up
  4. Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts
  5. Effect of residual kidney function and dialysis adequacy on chronic pruritus in dialysis patients
  6. Symptom Burden before and after Dialysis Initiation in Older Patients
  7. Reference intervals of urinary kidney injury biomarkers for middle-aged men and women determined by quantitative protein mass spectrometry
  8. The Epidemiology of Diabetic Kidney Disease
  9. Environmental factors and mobility predict COVID-19 seasonality in the Netherlands
  10. Quality of Life before and after the Start of Dialysis in Older Patients
  11. Depression, anxiety and quality of life of hemodialysis patients before and during the COVID-19 pandemic
  12. Internet-based treatment for depressive symptoms in hemodialysis patients: A cluster randomized controlled trial
  13. Itching in dialysis patients: impact on health-related quality of life and interactions with sleep problems and psychological symptoms—results from the RENINE/PROMs registry
  14. Health-Related Quality-of-Life Trajectories over Time in Older Men and Women with Advanced Chronic Kidney Disease
  15. Association Between Lipophilic Beta-Blockers and Depression in Diabetic Patients on Chronic Dialysis
  16. Serum Potassium and Mortality Risk in Hemodialysis Patients: A Cohort Study
  17. Comparable seasonal pattern for COVID-19 and flu-like illnesses
  18. Variation in glucocorticoid sensitivity and the relation with obesity
  19. Environmental factors and mobility predict COVID-19 seasonality
  20. Plasma fatty acids and kidney function decline in post-myocardial infarction patients of the Alpha Omega Cohort
  21. Can pollen explain the seasonality of flu-like illnesses in the Netherlands?
  22. The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery
  23. Lower gastrointestinal bleeding in a patient receiving sevelamer: Case report
  24. Superior Long-Term Survival for Simultaneous Pancreas–Kidney Transplantation as Renal Replacement Therapy: 30-Year Follow-up of a Nationwide Cohort
  25. Effect of different types of statins on kidney function decline and proteinuria: a network meta-analysis
  26. Dutch nOcturnal and hoME dialysis Study To Improve Clinical Outcomes (DOMESTICO): rationale and design
  27. Low Birth Weight and Kidney Function in Middle-Aged Men and Women: The Netherlands Epidemiology of Obesity Study
  28. Association of Initiation of Maintenance Dialysis with Functional Status and Caregiver Burden
  29. Dietary protein intake and kidney function decline after myocardial infarction: the Alpha Omega Cohort
  30. Geriatric Assessment and the Relation with Mortality and Hospitalizations in Older Patients Starting Dialysis
  31. Publisher Correction: Lower body mass index and mortality in older adults starting dialysis
  32. Lower body mass index and mortality in older adults starting dialysis
  33. Thoracic and abdominal pain in a 28-year-old woman with a failing kidney transplant
  34. Dyslipidemia and risk of renal replacement therapy or death in incident pre-dialysis patients
  35. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial
  36. Body-fat indicators and kidney function decline in older post-myocardial infarction patients: The Alpha Omega Cohort Study
  37. Obesity and risk of death or dialysis in younger and older patients on specialized pre-dialysis care
  38. Effect of dual compared to no or single renin-angiotensin system blockade on risk of renal replacement therapy or death in predialysis patients: PREPARE-2 study
  39. MP375DYSLIPIDEMIA AND RISK OF RENAL REPLACEMENT THERAPY OR DEATH IN PRE-DIALYSIS PATIENTS: PREPARE-2 STUDY
  40. SP055CARDIOVASCULAR RISK FACTORS, LIFESTYLE AND KIDNEY FUNCTION DECLINE IN STABLE OLDER POST-MYOCARDIAL INFARCTION PATIENTS RECEIVING OPTIMAL DRUG THERAPY: A PROSPECTIVE COHORT STUDY
  41. Listeria Endocarditis: A Diagnostic Challenge
  42. Kidney function and specific mortality in 60-80 years old post-myocardial infarction patients: A 10-year follow-up study
  43. Kidney dysfunction, systemic inflammation and mental well-being in elderly post-myocardial infarction patients
  44. Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis
  45. MP316BODY MASS INDEX AND KIDNEY FUNCTION DECLINE IN 60-80 YEARS OLD STATE-OF-THE-ART DRUG-TREATED POST-MYOCARDIAL INFARCTION PATIENTS
  46. SP293DUAL COMPARED TO SINGLE RENIN-ANGIOTENSIN SYSTEM INHIBITION AND RISK OF RENAL REPLACEMENT THERAPY OR DEATH IN PREDIALYSIS PATIENTS: PREPARE-2 STUDY
  47. Recipient obesity and outcomes after kidney transplantation: a systematic review and meta-analysis
  48. Effect of Omega-3 Fatty Acids on Kidney Function after Myocardial Infarction: The Alpha Omega Trial
  49. No effect of n-3 fatty acids supplementation on NT-proBNP after myocardial infarction: The Alpha Omega Trial
  50. No effect of n-3 fatty acids on high-sensitivity C-reactive protein after myocardial infarction: the Alpha Omega Trial
  51. An uncommon cause of Staphylococcus aureus sepsis
  52. Association of Blood Pressure with the Start of Renal Replacement Therapy in Elderly Compared with Young Patients Receiving Predialysis Care
  53. Obesity and Mortality Risk among Younger Dialysis Patients
  54. Effect of Obesity on the Outcome of Kidney Transplantation: A 20-Year Follow-Up
  55. Haemodialysis catheters increase mortality as compared to arteriovenous accesses especially in elderly patients
  56. A haemodialysis patient with back pain: brown tumour as a cause of spinal cord compression under cinacalcet therapy
  57. Reversible Rapidly Progressive Dementia with Parkinsonism Induced by Valproate in a Patient with Systemic Lupus Erythematosus
  58. Exclusion of a Case-Control Study From Meta-analysis
  59. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death
  60. Evaluation of the one-minute exercise test to detect peripheral arterial disease
  61. Unusual presentation of tumoral calcinosis in chronic renal failure: a case report
  62. Homocysteine and Risk of Ischemic Heart Disease and Stroke
  63. Hyperhomocysteinemia, Diabetes, and Cardiovascular Disease
  64. Hyperhomocysteinemia Is Associated With the Presence of Retinopathy in Type 2 Diabetes Mellitus
  65. Hyperhomocysteinemia Increases Risk of Death, Especially in Type 2 Diabetes
  66. Hyperhomocysteinaemia is not associated with isolated crural arterial occlusive disease: The Hoorn Study
  67. Classification of Congenital Anomalies of the Upper Limb
  68. Hyperhomocysteinaemia is not related to risk of distal somatic polyneuropathy: The Hoorn Study
  69. Reply from the authors
  70. The association of dietary fibres with glucose tolerance is partly explained by concomitant intake of thiamine: The Hoorn Study
  71. Serum homocysteine level and protein intake are related to risk of microalbuminuria: The Hoorn Study11See Editorial by Robinson and Dennis, p 281
  72. Correspondence
  73. Effects of Sex Steroids on Plasma Total Homocysteine Levels: A Study in Transsexual Males and Females
  74. Effects of Sex Steroids on Plasma Total Homocysteine Levels: A Study in Transsexual Males and Females
  75. Hyperhomocysteinemia Is Associated With an Increased Risk of Cardiovascular Disease, Especially in Non–Insulin-Dependent Diabetes Mellitus
  76. Does metformin increase the serum total homocysteine level in non-insulin-dependent diabetes mellitus?